Medical experts explore the optimization of patient referrals for bispecifics and CAR-T therapies through academic and community collaborations, addressing referral processes, challenges, and practical strategies with insights.
EP. 1: Importance of Collaboration between Academic and Community Centers
September 6th 2024Medical experts highlight the critical role of collaboration between academic and community physicians in managing multiple myeloma, focusing on coordinating care, maintaining communication, and ensuring centers are prepared for patient transitions.
EP. 2: Referral Process: Streamlining and Challenges Seen
September 6th 2024Medical experts discuss streamlining referrals to reduce treatment delays, optimizing resources, comparing outcomes in collaborative vs noncollaborative settings, and managing patient reluctance about academic center referrals.v
EP. 4: Similarities and Differences among Bispecifics: BCMA vs non-BCMA
September 13th 2024Medical experts examine differences and similarities in the referral process and treatment protocols for non–BCMA-targeted vs BCMA-targeted bispecific therapies, including aspects like step-up dosing and premedication.